MARKET

VANI

VANI

Vivani Medical
NASDAQ
1.260
-0.010
-0.79%
Opening 12:49 09/14 EDT
OPEN
1.260
PREV CLOSE
1.270
HIGH
1.284
LOW
1.240
VOLUME
104.32K
TURNOVER
--
52 WEEK HIGH
1.920
52 WEEK LOW
0.9228
MARKET CAP
113.66M
P/E (TTM)
-3.5107
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VANI last week (0831-0904)?
Weekly Report · 09/07 09:04
Weekly Report: what happened at VANI last week (0824-0828)?
Weekly Report · 08/31 09:04
Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
NASDAQ · 08/29 23:35
Weekly Report: what happened at VANI last week (0817-0821)?
Weekly Report · 08/24 09:04
Analysts Offer Insights on Healthcare Companies: Vivani Medical (VANI) and InspireMD (NSPR)
TipRanks · 08/18 14:00
Vivani Medical Updates Investors with Regulation FD Presentation
TipRanks · 08/17 12:29
Weekly Report: what happened at VANI last week (0810-0814)?
Weekly Report · 08/17 09:04
Lake Street Remains a Buy on Vivani Medical (VANI)
TipRanks · 08/14 13:15
More
About VANI
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.

Webull offers Vivani Medical Inc stock information, including NASDAQ: VANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VANI stock methods without spending real money on the virtual paper trading platform.